232.1 🎓 醫孞生版

232.1.0.1 📌 䞀頁重點

232.1.0.1.1 Microbiology + Life Cycle
  • Pathogen: Toxoplasma gondii — apicomplexan protozoan
  • Definitive host: CATS (felines) — only mammals in which sexual reproduction occurs
  • Intermediate host: humans + other warm-blooded animals (asexual reproduction)
  • Forms:
    • Oocyst: shed in cat feces (after primary feline infection); requires 1-5 days sporulation to be infectious
    • Tachyzoite: rapidly dividing in acute infection (host tissue invasion)
    • Bradyzoite: slowly dividing in tissue cysts (latent, lifelong)
232.1.0.1.2 Transmission
  • Ingestion of oocysts in cat feces (contaminated soil, water, vegetable, fruit, sandbox)
  • Ingestion of tissue cysts in undercooked meat (pork, lamb, beef, wild game)
  • Vertical (mother-to-fetus during pregnancy if primary infection)
  • Blood transfusion (rare)
  • Organ transplant from seropositive donor to seronegative recipient
232.1.0.1.3 Epidemiology
  • Seroprevalence: 30-50% of adults globally (varies by geography + dietary habits)
  • High prevalence: France, Brazil, parts of Africa, parts of Mediterranean (raw/undercooked meat consumption)
  • Lower: USA (~ 11%), UK
  • Most healthy adults asymptomatic
232.1.0.1.4 Clinical (Immunocompetent Acquired)
  • 80-90% asymptomatic
  • 10-20% symptomatic:
    • Mononucleosis-like illness: fever, cervical LAP (especially posterior cervical, painless), fatigue, malaise
    • Lasts weeks to months
    • Lab: atypical lymphocytes (less than EBV)
  • Rare immunocompetent severe: myocarditis, pneumonitis, hepatitis (especially in 2024+ outbreaks linked to specific strains)
232.1.0.1.5 Congenital Toxoplasmosis
  • 1° maternal infection during pregnancy → fetal infection
  • Transmission rate:
    • 1st trimester: low (15%) but severe disease
    • 2nd trimester: moderate (40%) + moderate severity
    • 3rd trimester: high (70%) but milder
  • Severe sequelae if untreated:
    • Chorioretinitis (#1; often reactivates years later)
    • Hydrocephalus
    • Intracerebral calcifications
    • Microcephaly or macrocephaly (hydrocephalus)
    • Intellectual disability
    • Hearing loss
    • Seizures
  • Most live-born congenital toxoplasmosis asymptomatic at birth but develop sequelae years later (especially chorioretinitis)
232.1.0.1.6 HIV + Toxoplasmosis (Reactivation)
  • Risk: HIV + CD4 < 100 + Toxo IgG positive (latent infection)
  • Toxoplasma encephalitis: most common manifestation
    • Headache, fever, focal neurological signs, seizures
    • MRI: multiple ring-enhancing lesions (basal ganglia + gray-white junction)
    • Differential: PCNSL (single + homogeneous enhancing), brain abscess, TB
  • Other reactivation: chorioretinitis, pneumonitis (severe in HIV), disseminated
232.1.0.1.7 Diagnosis
  • Serology: IgM (acute) + IgG (past or chronic) + IgG avidity (timing of infection)
  • PCR: amniotic fluid (vertical), CSF (reactivation), tissue
  • Imaging: MRI brain (reactivation in HIV), fetal US (congenital)
  • Tissue biopsy + IHC (definitive)
232.1.0.1.8 Treatment
232.1.0.1.8.1 Acute Immunocompetent
  • Mostly self-limited
  • Treatment for severe / persistent / immunocompromise
  • Same regimen as below if treatment indicated
232.1.0.1.8.2 Acute Maternal Infection
  • Spiramycin (prevents vertical transmission) until fetal infection confirmed
  • If fetal infection confirmed: sulfadiazine + pyrimethamine + leucovorin (after 1st trimester)
  • Specialty obstetric + ID coordination
232.1.0.1.8.3 Toxoplasma Encephalitis (HIV)
  • Sulfadiazine + Pyrimethamine + Leucovorin × 6 weeks
  • Alternative: TMP-SMX, clindamycin + pyrimethamine
  • Empirical if MRI ring lesions + IgG positive (don’t biopsy unless atypical or no response)
  • Steroid for mass effect / edema
  • ART (CD4 recovery)
  • Maintenance until CD4 > 200 for 3 months on ART
232.1.0.1.8.4 Ocular Toxoplasmosis
  • TMP-SMX (alternative)
  • Sulfadiazine + pyrimethamine
  • Steroid
232.1.0.1.8.5 Newborn Congenital
  • Sulfadiazine + pyrimethamine + leucovorin × 1 year
  • Monitor + treat sequelae
232.1.0.1.9 Prevention
  • Cat care: indoor cats, daily litter box changing (gloves, mask, hand wash), don’t feed raw meat
  • Pregnant women avoid:
    • Cleaning cat litter (delegate)
    • Undercooked meat (cook all meat to safe temperature, freeze < -12°C kills cysts)
    • Unwashed produce
    • Untreated water
  • Maternal screening: not universal in USA but routine in France, Italy, Austria
  • Pre-transplant screening: donor + recipient serology
232.1.0.1.10 2024 Notes
  • Atypical highly virulent strains in S America causing severe disease in immunocompetent
  • Outbreaks linked to water contamination (BC Canada historic, others)
  • TMP-SMX prophylaxis in HIV (CD4 < 100) reduces toxoplasma encephalitis dramatically

232.1.0.2 1⃣ Microbiology + Life Cycle Detail

232.1.0.2.1 Apicomplexan
  • Toxoplasma gondii — single species
  • Same phylum as Plasmodium, Babesia, Cryptosporidium
232.1.0.2.2 Forms
232.1.0.2.2.1 Oocyst (Environmental)
  • Shed by cats after primary acquisition
  • ~ 100 million oocysts shed by one infected cat over weeks
  • Requires 1-5 days sporulation to be infectious
  • Resistant to environmental conditions
  • Soil, water contamination
232.1.0.2.2.2 Tachyzoite (Acute)
  • Rapidly dividing intracellular form
  • Disseminates throughout host
  • Targets immune cells + various tissues
  • Eventually controlled by immunity → transformation to bradyzoite
232.1.0.2.2.3 Bradyzoite (Chronic)
  • Slowly dividing
  • Tissue cysts in brain, muscle, retina, heart
  • Lifelong latency in host
  • Reactivates when immunity compromised
232.1.0.2.3 Life Cycle
  1. Cat ingests prey infected with tissue cysts
  2. Bradyzoites released in cat intestine → sexual reproduction in epithelium
  3. Oocysts shed in feces
  4. After sporulation (1-5 d) → infectious
  5. Intermediate hosts (humans, livestock) ingest oocysts (soil, water) or tissue cysts (undercooked meat)
  6. Oocysts/cysts release sporozoites/bradyzoites in intestine → tachyzoites
  7. Dissemination throughout intermediate host
  8. Tissue cysts form (bradyzoites — latency)
  9. Cycle continues when cat eats intermediate host

232.1.0.3 2⃣ Transmission Routes

232.1.0.3.1 Foodborne
  • Undercooked meat with tissue cysts: pork, lamb, beef, wild game, ground meat
  • Cook to safe internal temperature or freeze < -12°C (10°F) ≥ 3 days kills cysts
232.1.0.3.2 Oocyst-Contaminated
  • Soil (sandbox, gardening)
  • Water (waterborne outbreaks rare but documented)
  • Vegetables / fruits contaminated with cat feces / soil
  • Cat litter handling
232.1.0.3.3 Vertical (Pregnancy)
  • 1° maternal infection during pregnancy
  • Pre-pregnancy infection rarely transmits (lifelong immunity)
  • HIV + immunocompromise reactivation can transmit (rare)
232.1.0.3.4 Blood / Tissue
  • Rare with screening
  • Transplant donor-recipient transmission documented
232.1.0.3.5 Cat Bites / Scratches
  • Generally not significant transmission

232.1.0.4 3⃣ Clinical — Immunocompetent Acquired

232.1.0.4.1 Asymptomatic (80-90%)
  • Most acute infections
  • Lifelong latency
  • Asymptomatic seroconversion
232.1.0.4.2 Symptomatic Acquired Toxoplasmosis
232.1.0.4.2.1 Mononucleosis-like Illness
  • Fever
  • Cervical lymphadenopathy (especially posterior cervical, painless, often persistent)
  • Fatigue, malaise
  • Myalgia
  • Pharyngitis
  • Atypical lymphocytes on smear (less than EBV mono)
  • Lasts weeks to months
  • Self-limited
232.1.0.4.2.2 Other Less Common
  • Myocarditis (rare)
  • Pneumonitis
  • Hepatitis
  • Polymyositis
  • Atypical strains (S America) — severe in immunocompetent
232.1.0.4.3 Ocular Toxoplasmosis (Acquired Cases)
  • Less common than congenital reactivation
  • Posterior chorioretinitis (mass, focal lesions)
  • Vision loss
  • Recurrent

232.1.0.5 4⃣ Congenital Toxoplasmosis

232.1.0.5.1 Pathogenesis
  • 1° maternal infection during pregnancy
  • Tachyzoites cross placenta → fetal infection
232.1.0.5.2 Trimester-Specific Outcomes
Trimester Transmission Rate Severity
1st ~ 15% Severe (often spontaneous abortion or major sequelae)
2nd ~ 40% Moderate
3rd ~ 70% Milder (more often asymptomatic at birth)
232.1.0.5.3 Classic Tetrad (Sabin)
  • Chorioretinitis
  • Hydrocephalus
  • Intracerebral calcifications
  • Intellectual disability + convulsions
232.1.0.5.4 Clinical at Birth
  • 90% asymptomatic at birth (especially 3rd trimester transmission)
  • Symptomatic at birth: severe with multi-organ involvement
    • Microcephaly OR macrocephaly (hydrocephalus)
    • Chorioretinitis (often bilateral)
    • Periventricular calcifications
    • Hepatosplenomegaly
    • Jaundice
    • Anemia, thrombocytopenia
    • Seizures
  • “Classic triad”: chorioretinitis + hydrocephalus + calcifications
232.1.0.5.5 Later Sequelae (Even Asymptomatic at Birth)
  • Chorioretinitis appears years later (most common late finding; reactivates)
  • Vision loss
  • Hearing loss
  • Intellectual disability
  • Cerebral palsy
  • Seizures
232.1.0.5.6 Diagnosis
232.1.0.5.6.1 Prenatal
  • Maternal IgM + IgG + IgG avidity (low avidity suggests recent infection)
  • PCR of amniotic fluid (after 18 weeks gestation) — sensitive for fetal infection
  • Fetal ultrasound (later changes — hydrocephalus, calcifications)
  • Fetal MRI
232.1.0.5.6.2 Postnatal
  • Newborn serology (compare with maternal — maternal IgG can persist)
  • Newborn IgM (own production) — confirms congenital infection
  • PCR of newborn blood, CSF, amniotic fluid
  • Examination: ophthalmologic, neurological, audiologic, imaging
  • Treatment regardless if congenital infection confirmed
232.1.0.5.7 Treatment
232.1.0.5.7.1 Maternal Treatment (Prevent Vertical Transmission)
  • Spiramycin (macrolide, doesn’t cross placenta well — used to prevent transmission)
  • Continued until pregnancy ends or fetal infection ruled out
  • Reduces transmission ~ 50%
232.1.0.5.7.2 Fetal Infection Confirmed
  • Sulfadiazine + Pyrimethamine + Leucovorin (after 1st trimester — pyrimethamine teratogenic)
  • Spiramycin continued
232.1.0.5.7.3 Newborn Confirmed
  • Sulfadiazine + Pyrimethamine + Leucovorin × 1 year
  • Long course critical for outcome
  • Sequelae monitoring + treatment

232.1.0.6 5⃣ HIV + Toxoplasma Reactivation

232.1.0.6.1 Risk
  • HIV + CD4 < 100 AND Toxo IgG positive (latent infection from prior exposure)
  • Other immunocompromise: BMT, organ transplant, chemo (less common)
232.1.0.6.2 Most Common Manifestation: Toxoplasma Encephalitis
  • Subacute (days-weeks)
  • Headache + fever + focal neurological signs + seizures + altered mental status
  • Hemiparesis, ataxia, aphasia, cranial nerve deficits
  • 90% in HIV-related Toxo
232.1.0.6.3 Imaging
  • MRI brain: multiple ring-enhancing lesions (basal ganglia + gray-white junction)
  • Edema
  • Differential:
    • PCNSL (single, homogeneously enhancing)
    • Brain abscess
    • TB
    • Other CNS infections
232.1.0.6.4 Differential CNS Lesions in HIV (CD4 < 100)
Feature Toxoplasmosis PCNSL
Lesions Multi-ring enhancing Often single, homogeneous
EBV PCR CSF Negative Positive (90%)
Thallium SPECT Negative Positive uptake
Response to empirical Toxo Tx Yes (1-2 wk) No
232.1.0.6.5 Empirical Treatment (vs Biopsy)
  • Standard: empirical Toxo Tx if MRI ring lesions + IgG positive + CD4 < 100
  • Brain biopsy reserved for:
    • Atypical presentation
    • Failure to respond to 1-2 wk empirical Tx
    • Single lesion + concerning for PCNSL
232.1.0.6.6 Treatment
232.1.0.6.6.1 Induction (6 weeks)
  • Sulfadiazine 1-1.5 g PO q6h + Pyrimethamine 200 mg PO × 1 → 75 mg PO qd + Leucovorin 10-25 mg PO qd
    • Steroid (dexamethasone) for edema / mass effect
232.1.0.6.6.2 Maintenance (Until Immune Recovery)
  • Lower-dose sulfadiazine + pyrimethamine + leucovorin
  • Until CD4 > 200 for 3 months on ART
232.1.0.6.6.3 Alternatives
  • TMP-SMX (alternative, similar efficacy)
  • Clindamycin + pyrimethamine + leucovorin
  • Atovaquone + pyrimethamine + leucovorin
232.1.0.6.6.4 ART
  • Critical — restore immunity
  • IRIS uncommon but possible
232.1.0.6.7 Prophylaxis
  • Primary: CD4 < 100 + Toxo IgG positive → TMP-SMX (also covers PJP)
  • Secondary: continue maintenance until immune recovery

232.1.0.7 6⃣ Ocular Toxoplasmosis

232.1.0.7.1 Forms
  • Congenital reactivation (most ocular Toxo)
  • Acquired (less common)
232.1.0.7.2 Clinical
  • Posterior chorioretinitis
  • Vitritis, focal retinal lesions
  • “Searchlight” pattern (active lesion + old scar)
  • Vision loss
  • Recurrent attacks
232.1.0.7.3 Diagnosis
  • Clinical (ophthalmology)
  • Anti-Toxo antibody titer (suspicion)
  • Aqueous humor PCR (occasionally)
232.1.0.7.4 Treatment
  • TMP-SMX or sulfadiazine + pyrimethamine + leucovorin × 4-6 wk
    • topical / oral steroid (selective)
  • Surgery rare

232.1.0.8 7⃣ Prevention

232.1.0.8.1 Pregnancy
  • Routine maternal serology in some countries (France, Italy, Austria)
  • USA: not universal — high-risk pregnant women + symptomatic
  • Pregnant women avoid:
    • Cleaning cat litter (delegate; if must, gloves + hand wash + daily change)
    • Undercooked meat (cook to safe temp; freeze < -12°C × 3 d kills cysts)
    • Unwashed produce
    • Untreated water
    • Gardening (gloves)
232.1.0.8.2 Cat Care (Pre-Pregnancy + Generally)
  • Keep cats indoors (less hunting → less acquisition)
  • Daily litter box changing (oocysts not infectious for 24 hr — daily prevents)
  • Feed cooked / commercial food (not raw meat)
  • Hand wash after handling
232.1.0.8.3 HIV / Immunocompromise
  • TMP-SMX prophylaxis CD4 < 100 + Toxo IgG positive (also covers PJP)
232.1.0.8.4 Pre-Transplant Screening
  • Donor + recipient serology
  • D+/R-: high-risk for primary transmission
  • Prophylaxis or monitoring